Buy or sell Datavant stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Datavant Stock

Healthcare Data Solutions

About Datavant Stock

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and sharing health data. The platform that the company offers organizes healthcare data for use in clinical trial decision-making. Its focus is on the employment of artificial intelligence to improve the clinical trial process and to improve the design and interpretation of clinical trials, helping pharmaceutical companies to manage the privacy, security, compliance, and trust required to enable safe data sharing. Travis May established Datavant in San Francisco, California in 2017.


Johnson & Johnson Innovation – JJDC


Octave Group


Funding History

April 2018$40.5M
October 2020$40.0M


Chief Executive Officer

Travis May

Chief Financial Officer

Mike Burwell


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: